Since the patent for Stelara (ustekinumab) expired in 2024, there are now four ustekinumab biosimilars available in the UK: Pyzchiva Steqeyma Uzpruvo Wenzela We expect that the majority of the patients on BADBIR who are currently taking Stelara will switch to one of...